Neonatal intraventricular hemorrhage

General Child Neurology

Updated 04.01.2024
Released 09.05.2012
Expires For CME 04.01.2027

Neonatal intraventricular hemorrhage

Authors: Josephine Miller MD, Aimee R Herdt PhD, Ian Griffin MD

See Contributor Disclosures

Editor: Bernard L Maria MD

Neonatal intraventricular hemorrhage

In This Article

Quick Link

Introduction

Overview

In this article, the authors review intraventricular hemorrhage in preterm and full-term neonates, covering symptomatology, etiology, management, and outcomes. Survival rates among preterm infants have continued to improve, and the number of infants with intraventricular hemorrhage and its neurodevelopmental sequelae has also risen (01; 25). As such, understanding this condition is crucial for clinicians.

Key points

	• Intraventricular hemorrhage originates in the germinal matrix of the infant born at less than 34 weeks’ gestation.
	• Intraventricular hemorrhage results from brain blood flow perturbations brought on by defective cerebral autoregulation in association with the various comorbidities of prematurity.
	• Management of intraventricular hemorrhage consists of monitoring for ventricular dilation and impaired drainage of CSF.
	• Neurologic sequelae may be severe and are related to both the severity and location of the hemorrhage.

Historical note and terminology

The advent of widespread positive pressure mechanical ventilation in the 1970s resulted in an approximately 300% increase in the incidence of intraventricular hemorrhage. The later use of antenatal steroids and surfactant administration as well as more stringent resuscitation policies to protect against significant fluctuations in cerebral blood flow did a lot to decrease the incidence of intraventricular hemorrhage in the 1990s (36). The number of infants born prematurely or at low birth weight in the U.S. continues to increase, and many more of these infants survive. Improved survivorship among these fragile infants means that cases of intraventricular hemorrhage remain prevalent in neonatal medicine (25).

Clinical manifestations

Presentation and course

The common clinical setting for intraventricular hemorrhage is the premature infant with respiratory distress requiring mechanical ventilation (96; 21). One study found a bimodal distribution of intraventricular hemorrhage in preterm infants, with just over half occurring within the first 6 hours of life and approximately 40% of cases occurring later but before day 7 to 9 of life (50).

The clinical presentation of intraventricular hemorrhage can vary widely and is often silent. Thus, many cases are only identified on routine brain imaging. However, when symptoms are present, they include abnormal tone or reflexes, apnea, pallor associated with anemia, respiratory distress, temperature instability, altered mental status, and seizures (28; 21). Other clinical characteristics associated with intraventricular hemorrhage include hypotension, hypercarbia, worsening base deficit, hypernatremia, and hypoglycemia (73). Subsequent outcomes depend on the progress of the hemorrhage and its effects on the ventricles and brain parenchyma (12). Extremely low gestational age, chorioamnionitis, being outborn, male gender, lack of antenatal steroids, vaginal birth, intubation at birth, and 5-minute Apgar score of less than 7 have been identified as risk factors for severe intraventricular hemorrhage (96; 21).

There are several classifications of intraventricular hemorrhage severity, although the definitions outlined by Papile are perhaps the most widely used (64). Grade III and IV hemorrhages are typically considered severe, although lesser grades of hemorrhage may also result in severe consequences.

Intraventricular hemorrhage grading (64; 28; 21)

Grade I: hemorrhage confined to the germinal matrix

Grade II: germinal matrix hemorrhage extends occupying less than 50% of the intraventricular space

Grade III: germinal matrix hemorrhage extends occupying more than 50% of the intraventricular space OR hemorrhage into a dilated ventricle

Grade IV: now recognized as periventricular hemorrhagic infarction (PVHI); extension of hemorrhage into the surrounding parenchyma causing venous occlusion

Prognosis and complications

Intraventricular hemorrhage can result in a multitude of long-term sequelae, including posthemorrhagic ventricular dilation, hydrocephalus, cerebral palsy, epilepsy, and cognitive delay (01; 19). One large cohort study reported that severe intraventricular hemorrhage affects 16% of all preterm infants born in the U.S. (79; 65). Data show that seizures are uncommon and accompany grade III or grade IV intraventricular hemorrhage in only about 3% of cases (19). The rate of associated hydrocephalus varies widely among studies, with some reporting rates as low as 25% to 28% and others documenting rates as high as 86%, although only 22% of those required shunt placement (19; 21).

It can be difficult to differentiate between grade III intraventricular hemorrhage and posthemorrhagic ventricular dilation (PHVD). PVHD is an important complication of grade III/IV intraventricular hemorrhage (95) and occurs in approximately 30% to 50% of patients (51; 25). It results from impaired absorption of CSF via two mechanisms. Acute hydrocephalus can occur within days secondary to impaired absorption of CSF due to particulate blood clots. Subacute hydrocephalus can arise within weeks due to an obliterative arachnoiditis in the posterior fossa, where blood collects after intraventricular hemorrhage (73). This obstructs the flow of CSF, most commonly at the level of the fourth ventricle. Of those diagnosed with PHVD, between 10% to 20% go on to require surgical intervention with shunt insertion (25). Traditional signs of increased cranial pressure and hydrocephalus may not be present until days to weeks after ventricular dilation has occurred (51). One sign of elevated increased cranial pressure in the neonate is splaying of the sagittal suture (73). In a premature infant, it takes less pressure to compress white matter than it takes to separate the sutures, which also requires stretching the dura (65), so progressive dilation of the ventricles should be carried out using cranial ultrasound, even in the absence of separation of the sutures.

Grade IV intraventricular hemorrhage can result in porencephalic cysts that communicate with the ventricles, most often affecting the parietal lobe (12). Fluid-filled cysts may cause obstruction to CSF flow, increased intracranial pressure, and reduced total brain volume (87; 42).

Periventricular white matter injury secondary to intraventricular hemorrhage is caused by ventricular dilation and subsequent compression of white matter, ischemia, and inflammatory cytokine response, all of which cause injury to pre-oligodendrocytes and subsequently compromise myelination (22; 65). White matter injury can be differentiated into two different categories: periventricular leukomalacia and punctate white matter lesions (PWML). Periventricular leukomalacia is characterized by focal coagulation necroses, white matter gliosis, and impaired myelination resulting in compromised grey matter. Periventricular leukomalacia with large areas of focal necrosis can result in the formation of cysts, ultimately designated cystic periventricular leukomalacia. PWML is caused by small areas of diffuse gliosis. The presence of cystic periventricular leukomalacia is strongly associated with later neuromotor dysfunction, such as cerebral palsy (28; 42).

The effects of low-grade hemorrhage are controversial. Some studies conclude that the neurodevelopmental outcomes of low-grade hemorrhage in extremely low gestational age infants do not differ from those without hemorrhage (66; 19). Others suggest an association between low-grade intraventricular hemorrhage and lower IQ at school age (70). One study found that preterm infants with cerebellar hemorrhage are more likely to need physical therapy sooner than preterm infants with intraventricular hemorrhage, but those with intraventricular hemorrhage are more likely to have attention deficits at 3 years of age compared to those with cerebellar hemorrhage (85). Although there is wide and often confusing variation among the studies of sequelae, the general pattern reveals greater levels of permanent disability with larger hemorrhages (89).

Clinical vignette

A 29-week premature infant was born following early labor with a birth weight of 1400 g. The infant required mechanical ventilation to maintain blood gases, and a chest x-ray showed hyaline membrane disease. The baby had been relatively stable since birth, but a routine cranial ultrasound on day 4 of life demonstrated a right germinal matrix hemorrhage (grade I). A scan 3 days later revealed blood extending into the ventricle and possibly into the parenchyma (grade IV). Ventricular size was followed by serial cranial ultrasounds and gradually increased for several weeks. The problem was temporized by ventriculoperitoneal shunt placement, and the ventricular size stabilized. At developmental follow-up at 18 months of life, delays were identified in multiple domains.

Biological basis

Etiology and pathogenesis

Intraventricular hemorrhage usually occurs in the clinical setting of the sick, premature infant who is receiving mechanical ventilation or is otherwise unstable. It may rarely occur in term infants.

Intraventricular hemorrhage in preterm infants is generally believed to arise from the germinal matrix (29; 67; 65; 95). The germinal matrix is an embryological structure lying below the lateral ventricles over the caudate nucleus. It is most prominent between 8 and 28 weeks’ gestation (51). It gives rise to both neuronal and glial cells and is important for grey matter development. Blood enters the microvessels of the germinal matrix via the Heubner artery (the distal medial striate branch of the anterior cerebral artery) and drains into the terminal veins, then onto the subependymal venous system. The germinal matrix evolutes by 36 to 37 weeks’ gestation.

Preterm infants are at risk of bleeding from the germinal matrix due to their immaturity, including reduced amounts of collagen IV, laminin, and fibronectin around the microvessels and reduced autoregulation of cerebral blood flow (91; 25; 65). Cerebral blood flow in preterm infants appears to be pressure-passive, so it is directly related to systemic blood pressure, especially in those of lower birth weight and gestational age (84; 78; 80). Increased cerebral blood flow passivity is associated with an increased risk of intraventricular hemorrhage (63; 80; 65). Preterm infants are prone to spikes in blood pressure in response to even minimal handling (eg, diaper changes), and the maximum peaks in blood pressure are higher in preterm infants who develop intraventricular hemorrhage (68). Blood pressure fluctuations may also be worsened by anatomical variants in the terminal veins, subependymal veins, or deeper venous systems that may impact venous drainage (82; 83; 46).

Once bleeding occurs in the germinal matrix, venous drainage can be impaired, which increases the risk of hemorrhage extension or intraparenchymal hemorrhage (65). PVHD can result from obstructed CSF flow by the hemorrhage, adhesive arachnoiditis, fibrosis of basal cistern or arachnoid granulation, or subependymal gliosis (65). The largest hemorrhages are seen in the least mature infants (less than 28 weeks’ gestation). Intraventricular hemorrhage may extend into the lateral ventricular system, frequently obstructing CSF flow in the posterior fossa and basilar cisterns and occasionally causing obstruction at the aqueduct of Sylvius and at the arachnoid villi. In addition to the mechanical insults to the brain parenchyma caused by blood products, adverse chemical reactions may also be initiated. Ventricular tissue can be exposed to reactive oxygen species formed by the release of iron, thereby damaging the neuronal axons and pre-oligodendrocytes that are important for myelination. Accumulation of thrombin and fibrin also contribute to parenchymal injury (13).

Other pathophysiological factors that may be associated with intraventricular hemorrhage include impaired coagulation, reduced circulating platelet mass, or monogenetic factors (98; 25; 65).

Isolation of Ureaplasma spp in amniotic fluid, or from the placental or amniotic membrane, has been associated with increased rates of intraventricular hemorrhage and bronchopulmonary dysplasia (45). Ureaplasma organisms may cross the immature blood-brain barrier in very low birth weight infants. PCR detection in serum is associated with a 2.5-fold increase in intraventricular hemorrhage; however, there was no association when Ureaplasma was isolated from the CSF (88). Ureaplasma spp may also provoke preterm labor and prolonged rupture of membranes, both of which are risk factors for intraventricular hemorrhage (45).

Intraventricular hemorrhage in term or near-term infants. Although the vast majority of intraventricular hemorrhage cases are preterm infants, it can rarely be seen in term or near-term infants. The reported incidence of intraventricular hemorrhage in term infants varies based on the definition and inclusion criteria. In one population-based study, two symptomatic cases of grade III or IV intraventricular hemorrhage were identified in nearly 36,000 term newborns, resulting in an incidence of 0.006% (81). A smaller study, also limited to symptomatic infants, found 33 cases and yielded a population incidence of approximately 0.05% (32). When asymptomatic infants are included, intraventricular hemorrhage incidence increases significantly. A study of 505 asymptomatic term infants who received cranial ultrasounds as part of a research study found intracranial bleeds in 4.6% of patients, primarily bilateral subependymal hemorrhages (35). Infants with hemorrhages had similar Apgar scores and resuscitation needs compared to those without but were more likely to be Black, small for gestational age, and delivered vaginally.

Symptoms of intracranial hemorrhage in term infants include seizures, apnea, poor feeding, and respiratory distress (32; 08; 02). Neurologic abnormalities may include irritability, truncal hypotonia, hypertonicity of extremities, and hyperreflexia (81). The location of intracranial hemorrhage varies and includes subependymal hemorrhage, choroid plexus, germinal matrix, thalamic hemorrhage, lobar hemorrhage, and intraventricular hemorrhage (74; 08; 02). Sinovenous thrombosis may be seen in association with intraventricular hemorrhage, especially in those with hemorrhagic involvement of the thalamus (94). Another study emphasized the strong association between intraventricular hemorrhage and thalamic hemorrhage. The authors reported that 12 of 19 infants who became symptomatic for intracranial hemorrhage during the first week of life were diagnosed with thalamic hemorrhage on CT imaging during the first month of life (74).

A prospective study from a single tertiary center identified several risk factors associated with intracranial hemorrhage in term and late preterm infants, including placental abruption, congenital heart disease, extracorporeal membrane oxygenation, or systemic anticoagulation of the infant (08). Perinatal depression and hypoxic-ischemic encephalopathy are also associated with increased intraventricular hemorrhage risk (33; 26).

The risk of intraventricular hemorrhage significantly rises in term infants requiring extracorporeal life support (ECLS), especially when combined with therapeutic hypothermia (18; 09). Hypothermia's impact on platelet function and the coagulation cascade, along with ECLS-related anticoagulation, contribute to increased intraventricular hemorrhage incidence (03; 09). Hemorrhage was more frequently observed in infants treated with therapeutic hypothermia (3/31) than in those who were not treated (1/31), even in the absence of ECLS, although these differences were not statistically significant (26).

The role of preeclampsia in intraventricular hemorrhage is inconsistent across studies, with some reporting it as protective and others as an associated risk factor (02; 56). More recent studies report no relationship between preeclampsia and intraventricular hemorrhage (90; 09). The role of thrombocytopenia and intraventricular hemorrhage in term infants is also inconclusive (10).

A small subset of hemorrhages may have underlying monogenetic causes (35; 27; 61; 43; 48). Mutations in COL4A1 and COL4A2 (which encode for collagen chains integral to the basement membrane of vascular structures in the brain, eyes, and kidneys) are associated with porencephaly and intraventricular hemorrhage (35; 27; 43). A work-up for a genetic etiology of disease, including for mutations in COL4A1 and COL4A2, should be considered in any patient with an antenatal parenchymal hemorrhage or porencephaly present at birth. Testing can be performed postnatally or prenatally using fetal DNA obtained by amniocentesis (16; 53; 56). To date, at least 21 COL4A1 and three COL4A2 pathogenic mutations have been identified (57).

Mutations in JAM3, which codes for a tight junction protein, are associated with severe hemorrhagic destruction of the brain as well as congenital cataracts and subependymal calcification. One Middle Eastern study describes a family (eight members) that each presented with devastating intracranial hemorrhage, resulting in death (61). All members had mutations in JAM3. Other possible genetic causes associated with intraventricular hemorrhage include MTHFR variants and endothelial nitric oxide synthase promoter polymorphisms (86; 47; 56). Interrogation of factor V Leiden mutations implicated in the pathomechanism of intraventricular hemorrhage has yielded variable and inconclusive results (34; 56).

Survival rates for term infants with intraventricular hemorrhage grades I and II are above 90% (19). Neurologic impairment at follow-up is common in those with symptomatic intraventricular hemorrhages (08), especially those with venous hemorrhagic infarcts. A Canadian systematic review evaluated data collected from 240 cases across 80 studies to better establish morbidity risks associated with neonatal intraventricular hemorrhage (19). Adverse outcomes were rare in grade I and II hemorrhages, but motor impairments were seen in 7%, developmental delays in 6%, and shunt placement in 12% in worse hemorrhages (grade III). Outcomes were worse in those with periventricular hemorrhagic infarction (motor impairment 10%; developmental delays 17%; seizure disorders 7%; shunt placement 17%).

Epidemiology

Current estimates suggest that intraventricular hemorrhage affects between 12,000 and 15,000 preterm infants in the U.S. annually and that roughly 45% of infants born at extremely low birth weight (< 1000 grams) will develop intraventricular hemorrhage (25; 50; 80). However, reported incidence rates are inconsistent, in part, due to variability in screening standards and differences among study cohorts (eg, average gestational age and birth weight). One study found the incidence of intraventricular hemorrhage to be extremely high in very low birth weight patients (71%), with an observed incidence of severe intraventricular hemorrhage at 29% (41). Conversely, another study diagnosed 20.2% of very low birth weight infants with intraventricular hemorrhage and only 5.2% with severe intraventricular hemorrhage (96). One study examining the presence of intraventricular hemorrhage among preterm infants documented autopsies between the years 1914 and 2015. The incidence of intraventricular hemorrhage was approximately 5% prior to 1960 but increased significantly to 50% after 1975, after the introduction of assisted ventilation in neonatal care. The incidence fell to 12% in 2005, a reduction the authors associated with antenatal steroids, “gentler” resuscitation and ventilation, and the use of surfactant (36; 96).

Although mortality has remained unchanged at approximately 30% to 40% (12; 55), a greater number and percentage of preterm and very low birth weight infants survive without major complications. The sum of these data is that the overall occurrence rate of intraventricular hemorrhage is less, but the clinical problem continues as more very low birth weight babies survive (89).

Prevention

Antenatal prevention. The most effective prevention of intraventricular hemorrhage is the prevention of premature birth, which may include the use of tocolytic agents (69). Magnesium is often given to mothers at risk for preterm delivery for fetal neuroprotection in addition to being a tocolytic. However, the evidence that magnesium reduces the risk of intraventricular hemorrhage in preterm newborns is poor (60; 23; 20). Alternatively, antenatal steroids, which are primarily given to enhance lung maturation, are clearly effective in reducing the risk and severity of intraventricular hemorrhage, regardless of which steroid (betamethasone or dexamethasone) is used (52; 60; 17; 31; 96; 41; 93). Additionally, some evidence suggests that exposure to the second stage of labor may increase the risk of intraventricular hemorrhage (24); however, data that cesarean section reduces intraventricular hemorrhage are contradictory (72; 14; 97; 50).

Peri-birth factors. Being born “out of hours” (eg, between midnight and 7 AM) may increase the risk of intraventricular hemorrhage in preterm infants, as may the need for early postnatal transfer (44; 37; 39).

The practice of immediately clamping the umbilical cord after delivery developed as a matter of convenience, but the practice is now being actively reassessed. Delayed cord clamping may lessen the need for red blood cell transfusion and also appears to decrease rates of intraventricular hemorrhage, bronchopulmonary dysplasia, and possibly overall mortality in preterm infants (05; 49). Conversely, immediate clamping may lead to hypotension and poor perfusion (38). The Committee on Obstetric Practice of the American College of Obstetricians and Gynecologists recommends delayed cord clamping in preterm infants for at least 30 to 60 seconds, when feasible (04). A meta-analysis comparing immediate cord clamping, delayed cord clamping, and umbilical cord milking found that although deferral of cord clamping reduced overall mortality in preterm infants, it did not significantly reduce the incidence of intraventricular hemorrhage (76).

Postnatal factors. Many neonatal intensive care units have developed “neurointensive care units” with the intent to reduce the incidence of intraventricular hemorrhage (31). The units incorporate a range of different nursing and medical practices; however, randomized controlled trials that critically examined these interventions show little good evidence in support of them (76). Head positioning, for example, has not been shown to affect the probability of intraventricular hemorrhage (15; 51).

The strongest evidence in support of intraventricular hemorrhage prevention is for the use of prophylactic indomethacin, which appears to reduce the risk and severity of intraventricular hemorrhage (54; 59; 76; 95). Research describing the use of other COX-inhibitors (eg, ibuprofen) is less conclusive (54; 59; 95). Early screening for, and treatment of, coagulation abnormalities may also reduce intraventricular hemorrhage, as well as the targeted use of fresh frozen plasma in coagulopathic infants (14; 62). Neither ethamsylate, phenobarbital, or caffeine appear to reduce the incidence of intraventricular hemorrhage (54; 40; 58; 75).

Diagnostic workup

The test of choice to screen for intraventricular hemorrhage is cranial ultrasound using anterior fontanelle (coronal), posterior fossa, and mastoid (parasagittal) views, which detect germinal matrix hemorrhage, hemorrhage into the ventricles, and parenchymal hemorrhage with good sensitivity and specificity (30). Routine cranial ultrasound is recommended in the first 4 to 7 days of life for infants born before 32 weeks’ gestational age, with repeat imaging at 4 to 6 weeks and once more at term. If abnormalities are detected, such as intraventricular hemorrhage or PHVD, a repeat cranial ultrasound is recommended 7 to 10 days later (28; 30; 50).

Cranial ultrasound is a good diagnostic tool for intraventricular hemorrhage due to its bedside accessibility and low cost. However, there are also limitations, such as low sensitivity for detecting white matter injury and abnormalities in myelination (42). MRI is not routinely indicated for infants born at less than 30 weeks’ gestational age but may be offered to high-risk infants (30). MRI is more sensitive than cranial ultrasound for reporting the presence and severity of white matter injury and is, therefore, better able to inform prognosis regarding neurodevelopmental outcomes (51; 28; 42). However, MRI may be difficult to perform on critically ill patients and may not always be readily available (21). CT imaging is no longer recommended as part of routine screening for intraventricular hemorrhage (30).

For late and moderately preterm infants, routine cranial ultrasound is not recommended but can be considered based on risk factors, such as placental abruption, need for vigorous resuscitation, hypotension requiring pressor support, severe acidosis, prolonged mechanical ventilation, confirmed sepsis, or pneumothorax (28; 30).

Assigning a severity or grade is important in the characterization of intraventricular hemorrhage. The grade of intraventricular hemorrhage is determined by both the presence and amount of blood and is determined by coronal ultrasound scan and parasagittal scan, respectively.

Management

Follow-up with serial compression ultrasonography is the best way to monitor for ventricular dilation and guide management considerations (22). Assessments should be done every 5 to 10 days after diagnosis. This is important because the signs and symptoms of hydrocephalus often declare themselves weeks after ventricular dilation (89; 28).

Infants with rapid head growth and progressive ventricular dilation, apnea, change in consciousness, full anterior fontanelle, or separated cranial sutures may require ventricular drainage or shunt placement. One of the mainstays of interventional therapy for ventricular dilation in the setting of intraventricular hemorrhage is lumbar puncture. Although lumbar puncture is typically a useful method of stabilization while neurosurgical assessment and coordination occurs, some studies have shown that performing up to three lumbar punctures can be adequate in preventing any further neurosurgical management in up to 25% of PVHD cases (13; 22). A Cochrane review concluded that early CSF drainage results in better neurodevelopmental outcomes when compared with late drainage of severely dilated ventricles (92). This was reaffirmed by the later ELVIS trial, which demonstrated that a low intervention threshold for lumbar puncture is associated with decreased mortality and morbidity in preterm patients with significant PHVD (13). There are a number of neurosurgical options, such as ventricular reservoir, temporary ventriculosubgaleal shunt, or permanent ventriculoperitoneal shunt (22; 55; 21). These interventions are associated with significant risk; in one study, 57% of patients treated with a ventricular reservoir for PHVH developed serious complications, including new intraventricular hemorrhage and ventriculitis (21). Approximately 20% to 40% of patients with PHVH later require ventriculoperitoneal shunt (06; 25). Risks associated with ventriculoperitoneal shunt include over-drainage (ie, slit ventricle syndrome), obstruction, or subsequent failure of the shunt (21).

An alternative surgical approach involves septostomy or neuroendoscopic fenestration of the foramen of Monro (11). This approach avoids more invasive procedures and may decrease the size of the affected ventricle and lead to an improved neurologic exam. One Chinese meta-analysis found that endoscopic surgery delivered better outcomes than treatment with extraventricular drainage alone, resulting in lower rates of ventriculoperitoneal shunt, intracranial rebleeding, and infection risk (55).

Nonsurgical management, such as the intraventricular administration of urokinase, has yielded conflicting results. The burden of cognitive impairment is lower amongst treated infants, but there is no decrease in need for ventriculoperitoneal shunt or improvement in overall mortality (21; 65). Acetazolamide reduces production of CSF and has been theorized as a useful temporizing treatment. However, research has found that the use of acetazolamide in patients with PHVH is associated with high rates of neurosurgical intervention and poorer neurodevelopmental outcomes (21; 65).

Although PHVD cannot be prevented, earlier CSF drainage based on modestly increased ventricular size, prior to the manifestation of any clinical symptoms, appears to be associated with improved neurodevelopmental outcomes (07; 51).

Outcomes

Long-term outcomes are defined by the associated major neurologic sequelae. Infants born at extremely low gestational ages (≤ 28 weeks) who suffer an intraventricular hemorrhage are at the highest risk for neurodevelopmental disabilities. Intraventricular hemorrhage in preterm infants can lead to motor impairment, developmental delay, hydrocephalus, and epilepsy (19). Risk factors associated with poor outcomes include neonatal brain injury, lung disease, sepsis, necrotizing enterocolitis, and exposure to surgery. Rates of impairment (cognitive delays 35%, abnormal motor outcomes 31%, cerebral palsy 42%) in infants diagnosed with intraventricular hemorrhage have improved (12); however, they tend to be worse in infants requiring surgical intervention for progressive ventricular dilation secondary to severe intraventricular hemorrhage (71).These patients are at an increased risk for cerebral palsy (76%), hearing impairment (8%), and vision impairment (13%) (77).

The mortality rate related to intraventricular hemorrhage remains unchanged from previous decades (30% to 40%), likely due, in part, to a shift towards more extremely preterm infants with higher neonatal death risk. High redirection of care rates in patients with PVHI also impacts survival.

References

01: Abdul Aziz AN, Thomas S, Murthy P, et al. Early inotropes use is associated with higher risk of death and/or severe brain injury in extremely premature infants. J Matern Fetal Neonatal Med 2020;33(16):2751-8. PMID 30563374
02: Afsharkhas L, Khalessi N, Karimi Panah M. Intraventricular hemorrhage in term neonates: sources, severity and outcome. Iran J Child Neurol 2015;9(3):34-9. PMID 26401151
03: Al Yazidi G, Boudes E, Tan X, Saint-Martin C, Shevell M, Wintermark P. Intraventricular hemorrhage in asphyxiated newborns treated with hypothermia: a look into incidence, timing and risk factors. BMC Pediatr 2015;15:106. PMID 26315402
04: American College of Obstetricians and Gynecologists’ Committee on Obstetric Practice. Delayed umbilical cord clamping after birth: ACOG Committee Opinion, Number 814. Obstet Gynecol 2020;136(6):100-6. PMID 33214530
05: Baer V, Lambert DK, Henry E, Snow GL, Christensen RD. Red blood cell transfusion of preterm neonates with a grade 1 intraventricular hemorrhage is associated with extension to a grade 3 or 4 hemorrhage. Transfusion 2011;51(9):1933-9. PMID 21382049
06: Behjati S, Emami-Naeini P, Nejat F, El Khashab M. Incidence of hydrocephalus and the need to ventriculoperitoneal shunting in premature infants with intraventricular hemorrhage: risk factors and outcome. Childs Nerv Syst 2011;27(6):985-9. PMID 21234576
07: Brouwer A, Groenendaal F, van Haastert IL, Rademaker K, Hanlo P, de Vries L. Neurodevelopmental outcome of preterm infants with severe intraventricular hemorrhage and therapy for post-hemorrhagic ventricular dilatation. J Pediatr 2008;152(5):648-54. PMID 18410767
08: Bruno CJ, Beslow LA, Witmer CM, et al. Haemorrhagic stroke in term and late preterm neonates. Arch Dis Child Fetal Neonatal Ed 2014;99(1):F48-53. PMID 23995383
09: Cashen K, Reeder RW, Shanti C, et al. Is therapeutic hypothermia during neonatal extracorporeal membrane oxygenation associated with intracranial hemorrhage? Perfusion 2018;33(5):354-62. PMID 29228894
10: Chen C, Wu S, Chen J, et al. Evaluation of the association of platelet count, mean platelet volume, and platelet transfusion with intraventricular hemorrhage and death among preterm infants. JAMA Netw Open 2022;5(10):e2237588. PMID 36260331
11: Chun HJ, Lee Y, Park HK, Kim YS. Neuroendoscopic fenestration of the foramen of Monro without septostomy for unilateral hydrocephalus following neonatal intraventricular hemorrhage. Childs Nerv Syst 2011;27(3):473-8. PMID 20811897
12: Cizmeci MN, de Vries LS, Ly LG, et al. Periventricular hemorrhagic infarction in very preterm infants: characteristic sonographic findings and association with neurodevelopmental outcome at age 2 years. J Pediatr 2020a;217:79-85.e1. PMID 31706634
13: Cizmeci MN, Groenendaal F, Liem KD, et al. Randomized controlled early versus late ventricular intervention study in posthemorrhagic ventricular dilatation: outcome at 2 years. J Pediatr 2020b;226:28-35.e3. PMID 32800815
14: Dani C, Poggi C, Ceciarini F, Bertini G, Pratesi S, Rubaltelli FF. Coagulopathy screening and early plasma treatment for the prevention of intraventricular hemorrhage in preterm infants. Transfusion 2009;49(12):2637-44. PMID 19682341
15: de Bijl-Marcus KA, Brouwer AJ, de Vries LS, van Wezel-Meijler G. The effect of head positioning and head tilting on the incidence of intraventricular hemorrhage in very preterm infants: a systematic review. Neonatology 2017;111(3):267-79. PMID 27923236
16: de Vries LS, Mancini GM. Intracerebral hemorrhage and COL4A1 and COL4A2 mutations, from fetal life into adulthood. Ann Neurol 2012;71(4):439-41. PMID 22447691
17: Deshmukh M, Patole S. Antenatal corticosteroids in impending preterm deliveries before 25 weeks' gestation. Arch Dis Child Fetal Neonatal Ed 2018;103(2):F173-6. PMID 29208662
18: Doymaz S, Zinger M, Sweberg T. Risk factors associated with intracranial hemorrhage in neonates with persistent pulmonary hypertension on ECMO. J Intensive Care 2015;3(1):6. PMID 25705431
19: Dunbar MJ, Woodward K, Leijser LM, Kirton A. Antenatal diagnosis of fetal intraventricular hemorrhage: systematic review and meta-analysis. Dev Med Child Neurol 2021;63(2):144-55. PMID 33094492
20: Edwards JM, Edwards LE, Swamy GK, Grotegut CA. Magnesium sulfate for neuroprotection in the setting of chorioamnionitis. J Matern Fetal Neonatal Med 2018;31(9):1156-60. PMID 283955489
21: Egesa WI, Odoch S, Odong RJ, et al. Germinal matrix-intraventricular hemorrhage: a tale of preterm infants. Int J Pediatr 2021;2021:6622598. PMID 33815512
22: El-Dib M, Limbrick DD Jr, Inder T, et al. Management of post-hemorrhagic ventricular dilatation in the infant born preterm. J Pediatr 2020;226:16-27.e3. PMID 32739263
23: Garcia Alonso L, Pumarada Prieto M, González Colmenero E, et al. Prenatal treatment with magnesium sulphate: initial clinical outcomes in preterm infants less than 29 weeks and correlation with neonatal magnesium levels. [Article in Spanish] An Pediatr (Barc) 2017;86(3):135-41. PMID 27282203
24: Gawade PL, Whitcomb BW, Chasan-Taber L, et al. Second stage of labor and intraventricular hemorrhage in early preterm infants in the vertex presentation. J Matern Fetal Neonatal Med 2013;26(13):1292-8. PMID 23484821
25: Gilard V, Tebani A, Bekri S, Marret S. Intraventricular hemorrhage in very preterm infants: a comprehensive review. J Clin Med 2020;9(8):2447. PMID 32751801
26: Gorelik N, Faingold R, Daneman A, Epelman M. Intraventricular hemorrhage in term neonates with hypoxic-ischemic encephalopathy: a comparison study between neonates treated with and without hypothermia. Quant Imaging Med Surg 2016;6(5):504-9. PMID 27942469
27: Gould DB, Phalan FC, Breedveld GJ, et al. Mutations in Col4a1 cause perinatal cerebral hemorrhage and porencephaly. Science 2005;308(5725):1167-71. PMID 15905400
28: Guillot M, Chau V, Lemyre B. Routine imaging of the preterm neonatal brain. Paediatr Child Health 2020;25(4):249-62. PMID 32540742
29: Hambleton G, Wigglesworth JS. Origin of intraventricular hemorrhage in the preterm infant. Arch Dis Child 1976;51(9):651-9. PMID 999324
30: Hand IL, Shellhaas RA, Milla SS, et al. Routine neuroimaging of the preterm brain. Pediatrics 2020;146(5):e2020029082. PMID 33106343
31: Handley SC, Passarella M, Lee HC, Lorch SA. Incidence trends and risk factor variation in severe intraventricular hemorrhage across a population based cohort. J Pediatr 2018;200:24-9. PMID 29754865
32: Hanigan WC, Powell FC, Miller TC, Wright RM. Symptomatic intracranial hemorrhage in full-term infants. Childs Nerv Syst 1995a;11(12):698-707. PMID 8750952
33: Hanigan WC, Powell FC, Palagallo G, Miller TC. Lobar hemorrhages in full-term neonates. Childs Nerv Syst 1995b;11(5):276-80. PMID 7648568
34: Harteman JC, Groenendaal F, van Haastert IC, et al. Atypical timing and presentation of periventricular haemorrhagic infarction in preterm infants: the role of thrombophilia. Dev Med Child Neurol 2012;54(2):140-7. PMID 22098125
35: Hayden CK Jr., Shattuck KE, Richardson CJ, Ahrendt DK, House R, Swischuk LE. Subependymal germinal matrix hemorrhage in full-term neonates. Pediatrics 1985;75(4):714-8. PMID 3885154
36: Hefti MM, Trachtenberg FL, Haynes RL, Hassett C, Volpe JJ, Kinney HC. A century of germinal matrix intraventricular hemorrhage in autopsied premature infants: a historical account. Pediatr Dev Pathol 2016;19(2):108-14. PMID 26372101
37: Helenius K, Longford N, Lehtonen L, et al. Association of early postnatal transfer and birth outside a tertiary hospital with mortality and severe brain injury in extremely preterm infants: observational cohort study with propensity score matching. BMJ 2019;367:l5678. PMID 31619384
38: Hemmati F, Sharma D, Namavar Jahromi B, Salarian L, Farahbakhsh N. Delayed cord clamping for prevention of intraventricular hemorrhage in preterm neonates: a randomized control trial. J Matern Fetal Neonatal Med 2022;35(19):3633-9. PMID 33092420
39: Hirata K, Kimura T, Hirano S, et al. Outcomes of outborn very-low-birth-weight infants in Japan. Arch Dis Child Fetal Neonatal Ed 2021;106(2):131-6. PMID 32788390
40: Hunt R, Hey E. Ethamsylate for the prevention of morbidity and mortality in preterm or very low birth weight infants. Cochrane Database Syst Rev 2010;(1):CD004343. PMID 20091562
41: Hwang-Bo S, Seo YM, Oh MY, Im SA, Youn YA. The prognosis of refractory hypotension and severe intraventricular hemorrhage in very low birth weight infants. Medicine (Baltimore) 2022;101(30):e29598. PMID 35905281
42: Inder TE, de Vries LS, Ferriero DM, et al. Neuroimaging of the preterm brain: review and recommendations. J Pediatr 2021;237:276-87.e4. PMID 34146549
43: Jeanne M, Labelle-Dumais C, Jorgensen J, et al. COL4A2 mutations impair COL4A1 and COL4A2 secretion and cause hemorrhagic stroke. Am J Hum Genet 2012;90(1):91-101. PMID 22209247
44: Jensen EA, Lorch SA. Association between off-peak hour birth and neonatal morbidity and mortality among very low birth weight infants. J Pediatr 2017;186:41-8.e4. PMID 28284476
45: Kasper DC, Mechtler TP, Bohm J, et al. In utero exposure to Ureaplasma spp is associated with increased rate of bronchopulmonary dysplasia and intraventricular hemorrhage in preterm infants. J Perinat Med 2011;39(3):331-6. PMID 21526978
46: Kent T, Sinha V, Ceyhan E, et al. Deep cerebral venous abnormalities in premature babies with GMH-IVH: a single-centre retrospective study. BMJ Paediatr Open 2023;7(1):e001853. PMID 37160379
47: Kloppenborg RP, Nederkoorn PJ, van der Graaf Y, Geerlings MI. Homocysteine and cerebral small vessel disease in patients with symptomatic atherosclerotic disease. The SMART-MR study. Atherosclerosis 2011;216(2):461-6. PMID 21411090
48: Koene S, Peeters-Scholte CMPCD, Knijnenburg J, et al. Intracerebral hemorrhage in a neonate with an intragenic COL4A2 duplication. Am J Med Genet A 2021;185(2):571-4. PMID 33247988
49: Kumbhat N, Eggleston B, Davis AS, et al. Umbilical cord milking vs delayed cord clamping and associations with in-hospital outcomes among extremely premature infants. J Pediatr 2021;232:87-94.e4. PMID 33417919
50: Law JB, Wood TR, Gogcu S, et al. Intracranial hemorrhage and 2-year neurodevelopmental outcomes in infants born extremely preterm. J Pediatr 2021;238:124-34.e10. PMID 34217769
51: Leijser LM, de Vries L. Chapter 8 - Preterm brain injury: germinal matrix–intraventricular hemorrhage and post-hemorrhagic ventricular dilatation. Handbook of Clinical Neurology. Elsevier, 2019:173-99.
52: Leviton A, Kuban KC, Pagano M, Allred EN, Van Marter L. Antenatal corticosteroids appear to reduce the risk of postnatal germinal matrix hemorrhage in intubated low birth weight newborns. Pediatrics 1993;91(6):1083-8. PMID 8502506
53: Lichtenbelt KD, Pistorius LR, De Tollenaer SM, Mancini GM, De Vries LS. Prenatal genetic confirmation of a COL4A1 mutation presenting with sonographic fetal ntracranial hemorrhage. Ultrasound Obstet Gynecol 2012;39(6):726-7. PMID 22223490
54: McCrea HJ, Ment LR. The diagnosis, management, and postnatal prevention of intraventricular hemorrhage in the preterm neonate. Clin Perinatol 2008;35(4):777-92, vii. PMID 19026340
55: Mei L, Fengqun M, Qian H, Dongpo S, Zhenzhong G, Tong C. Exploration of efficacy and safety of interventions for intraventricular hemorrhage: a network meta-analysis. World Neurosurg 2020;136:382-9.e6. PMID 31698131
56: Ment LR, Aden U, Bauer CR, et al. Genes and environment in neonatal intraventricular hemorrhage. Semin Perinatol 2015;39(8):592-603. PMID 25616117
57: Meuwissen ME, Halley DJ, Smit LS, et al. The expanding phenotype of COL4A1 and COL4A2 mutations: clinical data on 13 newly identified families and a review of the literature. Genet Med 2015;17(11):843-53. PMID 25719457
58: Miao Y, Liu W, Zhao S, et al. Effect of prophylactic caffeine in the treatment of apnea in very low birth weight infants: a meta-analysis. J Matern Fetal Neonatal Med 2023.
59: Mitra S, de Boode WP, Weisz DE, Shah PS. Interventions for patent ductus arteriosus (PDA) in preterm infants: an overview of Cochrane Systematic Reviews. Cochrane Database Syst Rev 2023;4(4):CD013588. PMID 37039501
60: Mittendorf R, Dammann O, Lee KS. Brain lesions in newborns exposed to high-dose magnesium sulfate during preterm labor. J Perinatol 2006;26(1):57-63. PMID 16319938
61: Mochida GH, Ganesh VS, Felie JM, et al. A homozygous mutation in the tight-junction protein JAM3 causes hemorrhagic destruction of the brain, subependymal calcification, and congenital cataracts. Am J Hum Genet 2010;87(6):882-9. PMID 21109224
62: Mohamed MA, Aly H. Transport of premature infants is associated with increased risk for intraventricular hemorrhage. Arch Dis Child Fetal Neonatal Ed 2010;95(6):F403-7. PMID 20584801
63: O'Leary H, Gregas MC, Limperopoulos C, et al. Elevated cerebral pressure passivity is associated with prematurity-related intracranial hemorrhage. Pediatrics 2009;124(1):302-9. PMID 19564313
64: Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978;92(4):529-34. PMID 305471
65: Park YS. Perspectives: understanding the pathophysiology of intraventricular hemorrhage in preterm infants and considering of the future direction for treatment. J Korean Neurosurg Soc 2023;66(3):298-307. PMID 36858804
66: Payne AH, Hintz SR, Hibbs AM, et al. Neurodevelopmental outcomes of extremely low-gestational-age neonates with low-grade periventricular-intraventricular hemorrhage. JAMA Pediatr 2013;167(5):451-9. PMID 23460139
67: Pazandak C, Mir IN, Brown LS, Chalak LF. Placental pathology, cerebral blood flow, and intraventricular hemorrhage in preterm infants: is there a link? Pediatr Neurol 2020;108:65-9. PMID 32451157
68: Perry EH, Bada HS, Ray JD, Korones SB, Arheart K, Magill HL. Blood pressure increases, birth weight-dependent stability boundary, and intraventricular hemorrhage. Pediatrics 1990;85(5):727-32. PMID 2330232
69: Pinto Cardoso G, Houivet E, Marchand-Martin L, et al. Association of intraventricular hemorrhage and death with tocolytic exposure in preterm infants. JAMA Netw Open 2018;1(5):e182355. PMID 30646165
70: Rees P, Callan C, Chadda KR, et al. Childhood outcomes after low-grade intraventricular haemorrhage: a systematic review and meta-analysis. Dev Med Child Neurol 2024;66(3):282-9. PMID 37488717
71: Rees P, Callan C, Chadda KR, et al. Preterm brain injury and neurodevelopmental outcomes: a meta-analysis. Pediatrics 2022;150(6):e2022057442. PMID 36330752
72: Riskin A, Riskin-Mashiah S, Bader D, et al. Delivery mode and severe intraventricular hemorrhage in single, very low birth weight, vertex infants. Obstet Gynecol 2008;112(1):21-8. PMID 18591303
73: Robinson S. Neonatal posthemorrhagic hydrocephalus from prematurity: pathophysiology and current treatment concepts. J Neurosurg Pediatr 2012;9(3):242-58. PMID 22380952
74: Roland EH, Flodmark O, Hill A. Thalamic hemorrhage with intraventricular hemorrhage in the full-term newborn. Pediatrics 1990;85(5):737-42. PMID 2330233
75: Romantsik O, Smit E, Odd DE, Bruschettini M. Postnatal phenobarbital for the prevention of intraventricular haemorrhage in preterm infants. Cochrane Database Syst Rev 2023;3(3):CD001691. PMID 36924438
76: Seidler AL, Aberoumand M, Hunter KE, et al. Deferred cord clamping, cord milking, and immediate cord clamping at preterm birth: a systematic review and individual participant data meta-analysis. Lancet 2023;402(10418)2209-22. PMID 37977169
77: Shankaran S, Bajaj M, Natarajan G, et al. Outcomes following post-hemorrhagic ventricular dilatation among infants of extremely low gestational age. J Pediatr 2020;226:36-44.e3. PMID 32739261
78: Soul JS, Hammer PE, Tsuji M, et al. Fluctuating pressure-passivity is common in the cerebral circulation of sick premature infants. Pediatr Res 2007;61(4):467-73. PMID 17515873
79: Stoll BJ, Hansen NI, Bell EF, et al. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993–2012. JAMA 2015;314(10):1039-51. PMID 26348753
80: Sunwoo J, Zavriyev AI, Kaya K, et al. Diffuse correlation spectroscopy blood flow monitoring for intraventricular hemorrhage vulnerability in extremely low gestational age newborns. Sci Rep 2022;12(1):12798. PMID 35896691
81: Szpecht D, Frydryszak D, Miszczyk N, Szymankiewicz M, Gadzinowski J. The incidence of severe intraventricular hemorrhage based on retrospective analysis of 35939 full-term newborns-report of two cases and review of literature. Childs Nerv Syst 2016;32(12):2447-51. PMID 27392444
82: Taylor GA. Effect of germinal matrix hemorrhage on terminal vein position and patency. Pediatr Radiol 1995;25 Suppl 1:S37-40. PMID 8577549
83: Tortora D, Martinetti C, Severino M, et al. The effects of mild germinal matrix-intraventricular haemorrhage on the developmental white matter microstructure of preterm neonates: a DTI study. Eur Radiol 2018;28(3):1157-66. PMID 28956133
84: Tsuji M, Saul JP, du Plessis A, et al. Cerebral intravascular oxygenation correlates with mean arterial pressure in critically ill premature infants. Pediatrics 2000;106(4):625-32. PMID 11015501
85: Uccella S, Parodi A, Calevo MG, et al. Influence of isolated low-grade intracranial haemorrhages on the neurodevelopmental outcome of infants born very low birthweight. Dev Med Child Neurol 2023. [Epub ahead of print] PMID 36998157
86: Vannemreddy P, Notarianni C, Yanamandra K, Napper D, Bocchini J. Is an endothelial nitric oxide synthase gene mutation a risk factor in the origin of intraventricular hemorrhage? Neurosurg Focus 2010;28(1):E11. PMID 20043715
87: Vasileiadis G, Gelman N, Han VK, et al. Uncomplicated intraventricular hemorrhage is followed by reduced cortical volume at near-term age. Pediatr 2004;114(3):e367-72. PMID 15342899
88: Viscardi RM. Ureaplasma species: role in neonatal morbidities and outcomes. Arch Dis Child Fetal Neonatal Ed 2014;99(1):F87-92. PMID 23960141
89: Volpe JJ. Preterm intraventricular hemorrhage/posthemorrhagic hydrocephalus. Neurology of the newborn. 6th edition. Philadelphia: WB Saunders Company, 2018:637-98.
90: von Lindern JS, van den Bruele T, Lopriore E, Walther FJ. Thrombocytopenia in neonates and the risk of intraventricular hemorrhage: a retrospective cohort study. BMC Pediatr 2011;11:16. PMID 21314921
91: Wei W, Xin-Ya S, Cai-Dong L, Zhong-Han K, Chun-Peng C. Relationship between extracellular matrix both in choroid plexus and the wall of lateral ventricles and intraventricular hemorrhage in preterm neonates. Clin Anat 2000;13(6):422-8. PMID 11111893
92: Whitelaw A, Lee-Kelland R. Repeated lumbar or ventricular punctures in newborns with intraventricular haemorrhage. Cochrane Database Syst Rev 2017;4(4):CD000216. PMID 28384379
93: Williams MJ, Ramson JA, Brownfoot FC. Different corticosteroids and regimens for accelerating fetal lung maturation for babies at risk of preterm birth. Cochrane Database Syst Rev 2022;8(8):CD006764. PMID 35943347
94: Wu YW, Hamrick SE, Miller SP, et al. Intraventricular hemorrhage in term neonates caused by sinovenous thrombosis. Ann Neurol 2003;54(1):123-6. PMID 12838529
95: Yao SL, Smit E, Odd D. The effectiveness of interventions to prevent intraventricular haemorrhage in premature infants: a systematic review and network meta-analysis. J Neonatal Perinatal Med 2023;16(1):5-20. PMID 36591663
96: Yeo KT, Thomas R, Chow SS, et al. Improving incidence trends of severe intraventricular haemorrhages in preterm infants <32 weeks gestation: a cohort study. Arch Dis Child Fetal Neonatal Ed 2020;105(2):145-50. PMID 31201252
97: Zhu W, Gao Y, Chang CF, Wan JR, Zhu SS, Wang J. Mouse models of intracerebral hemorrhage in ventricle, cortex, and hippocampus by injections of autologous blood or collagenase. PLoS One 2014;9(5):e97423. PMID 24831292
98: Zisk JL, Mackley A, Christensen RD, Paul DA. Is a small platelet mass associated with intraventricular hemorrhage in very low-birth-weight infants? J Perinatol 2011;31(12):776-9. PMID 21527906
99: References especially recommended by the author or editor for general reading.

Contributors

All contributors' financial relationships have been reviewed and mitigated to ensure that this and every other article is free from commercial bias.

Authors

Josephine Miller MD

Dr. Miller of Morristown Medical Center has no relevant financial relationships to disclose.
See Profile
Aimee R Herdt PhD

Dr. Herdt of MidAtlantic Neonatology Associates has no relevant financial relationships to disclose.
See Profile
Ian Griffin MD

Dr. Griffin of Mid-Atlantic Neonatal Associates has no relevant financial relationships to disclose.
See Profile

Editor

Bernard L Maria MD

Dr. Maria of Thomas Jefferson University has no relevant financial relationships to disclose.
See Profile

Former Authors

Stephen L Nelson Jr MD PhD

Patient Profile

Age range of presentation: 0-1 month
Sex preponderance: male>female
Heredity: none
Population groups selectively affected: none
Occupation groups selectively affected: none

ICD & OMIM codes

ICD-9: Intraventricular hemorrhage: 772.1
ICD-10: Acquired periventricular cysts of newborn: P91.1

Communicating hydrocephalus: G91.0

Intraventricular (nontraumatic) hemorrhage, grade 1, of newborn: P52.0

Intraventricular (nontraumatic) hemorrhage, grade 2, of newborn: P52.1

Intraventricular (nontraumatic) hemorrhage, grade 3, of newborn: P52.21

Intraventricular (nontraumatic) hemorrhage, grade 4, of newborn: P52.22

Unspecified intraventricular (nontraumatic) hemorrhage of newborn: P52.3

Post-traumatic hydrocephalus: G91.3

Preterm newborn, unspecified weeks of gestation: P07.30

This is an article preview.
Start a Free Account
to access the full version.

Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125

Neonatal intraventricular hemorrhage

Associated Disorders

cerebral palsy
chronic lung disease
developmental delay
hyaline membrane disease
prematurity
- retinopathy of prematurity

Differential Diagnosis

meningitis
sepsis
apnea of prematurity
seizures due to other causes
drug withdrawal
- metabolic disorder

Neonatal intraventricular hemorrhage

Neonatal intraventricular hemorrhage

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Clinical vignette

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Differential diagnosis

Confusing conditions

Diagnostic workup

Management

Outcomes

References

Contributors

Authors

Editor

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview.
Start a Free Account
to access the full version.

Questions or Comment?

Also in This Category

Acute cerebellar ataxia in children

Zika virus: neurologic complications

Cerebral edema in childhood

CNS germinoma

Vein of Galen malformations

Patent foramen ovale

Migraine in childhood

Neonatal opioid withdrawal syndrome

Neonatal intraventricular hemorrhage

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Clinical vignette

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Differential diagnosis

Confusing conditions

Diagnostic workup

Management

Outcomes

References

Contributors

Authors

Editor

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview. Start a Free Account to access the full version.

Questions or Comment?

Also in This Category

Acute cerebellar ataxia in children

Zika virus: neurologic complications

Cerebral edema in childhood

CNS germinoma

Vein of Galen malformations

Patent foramen ovale

Migraine in childhood

Neonatal opioid withdrawal syndrome

This is an article preview.
Start a Free Account
to access the full version.